# Therapeutic Applications

**Doc-Type:** Discovery Module | Version 2.0 | Updated 2025-12-24

---

## Overview

The p-adic geometric framework enables multiple therapeutic applications for HIV - from vaccine design to personalized treatment optimization to novel glycan editing approaches.

---

## Application Roadmap

```mermaid
timeline
    title HIV P-Adic Applications Timeline
    section Immediate
        Drug Combo Optimization : Ready now
        Epitope Screening : Ready now
    section 6-12 Months
        Resistance Prediction Tool : Development
        Cross-clade Analysis : Validation
    section 1-2 Years
        Vaccine Immunogens : Wet lab testing
        Clinical Correlation : Data access
    section 3-5 Years
        Glycan Editing Therapy : Novel approach
        Functional Cure : Long-term goal
```

---

## Application Overview

<div align="center">
  <img src="images/hiv_therapeutic_landscape_concept.png" width="800" alt="HIV Therapeutic Landscape">
  <p><em>Figure 1: Integrated Therapeutic Landscape - From molecular drug design to functional cures.</em></p>
</div>

```mermaid
flowchart TB
    subgraph APPLICATIONS["<b>7 Therapeutic Applications</b>"]
        A1["<b>1. Vaccine Design</b><br/>Sentinel glycan removal"]
        A2["<b>2. Resistance Prediction</b><br/>Clinical decision support"]
        A3["<b>3. Combo Optimization</b><br/>Maximize escape barrier"]
        A4["<b>4. Elite Controller Research</b><br/>Geometric trap identification"]
        A5["<b>5. Glycan Editing</b><br/>Novel therapeutic"]
        A6["<b>6. Universal Targets</b><br/>Cross-clade analysis"]
        A7["<b>7. Computational Platform</b><br/>API for researchers"]
    end

    PADIC["<b>P-Adic Framework</b><br/>3-Adic Codon Encoder"] --> APPLICATIONS

    style PADIC fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style A1 fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
    style A2 fill:#10b981,stroke:#059669,color:#ffffff,stroke-width:2px
    style A3 fill:#14b8a6,stroke:#0d9488,color:#ffffff,stroke-width:2px
    style A4 fill:#06b6d4,stroke:#0891b2,color:#ffffff,stroke-width:2px
    style A5 fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:2px
    style A6 fill:#ec4899,stroke:#db2777,color:#ffffff,stroke-width:2px
    style A7 fill:#f97316,stroke:#ea580c,color:#ffffff,stroke-width:2px
```

---

## Application 1: Vaccine Immunogen Design

### Concept

```mermaid
flowchart LR
    subgraph DESIGN["<b>Immunogen Design Pipeline</b>"]
        BG505["<b>BG505 SOSIP.664</b>"]
        MUT["<b>Introduce N→Q</b><br/>at sentinel sites"]
        EXPRESS["<b>Express & Purify</b>"]
        TEST["<b>Test bnAb Binding</b>"]
        IMMUNIZE["<b>Animal Immunization</b>"]
    end

    BG505 --> MUT --> EXPRESS --> TEST --> IMMUNIZE

    PADIC["<b>P-Adic Analysis</b>"] -->|"Identifies<br/>sentinel sites"| MUT

    style PADIC fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style BG505 fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:2px
    style IMMUNIZE fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
```

### Recommended Constructs

```mermaid
flowchart TB
    subgraph CONSTRUCTS["<b>Vaccine Immunogen Designs</b>"]
        C1["<b>DESIGN 1: Triple Sentinel</b><br/>N58Q + N103Q + N204Q<br/><br/>Targets: V1/V2 apex + V3 supersite<br/>bnAbs: PG9, PG16, PGT121, PGT128"]

        C2["<b>DESIGN 2: V1/V2 Focused</b><br/>N103Q + N107Q<br/><br/>Targets: V1/V2 apex only<br/>bnAbs: PG9, PG16, PGT145"]

        C3["<b>DESIGN 3: Sequential</b><br/>Prime: Deglycosylated (3-site)<br/>Boost: Native Env<br/><br/>Strategy: Broad prime + affinity maturation"]
    end

    style C1 fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:3px
    style C2 fill:#10b981,stroke:#059669,color:#ffffff,stroke-width:2px
    style C3 fill:#14b8a6,stroke:#0d9488,color:#ffffff,stroke-width:2px
```

---

## Application 2: Drug Resistance Prediction

### Pipeline

```mermaid
flowchart LR
    subgraph PREDICT["<b>Resistance Prediction Pipeline</b>"]
        SEQ["<b>Patient<br/>Sequence</b>"] --> ENCODE["<b>3-Adic<br/>Encoding</b>"]
        ENCODE --> CALC["<b>Calculate<br/>Escape d</b>"]
        CALC --> RANK["<b>Rank<br/>Mutations</b>"]
        RANK --> GUIDE["<b>Treatment<br/>Guidance</b>"]
    end

    DB["<b>Stanford HIVDB</b>"] --> |"Known mutations"| ENCODE

    style GUIDE fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
    style SEQ fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style DB fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:2px
```

### Clinical Decision Support

```mermaid
flowchart TB
    subgraph DECISION["<b>Treatment Selection</b>"]
        Q1{"<b>Patient<br/>HLA Type?</b>"}
        Q2{"<b>Current<br/>Regimen?</b>"}
        Q3{"<b>Resistance<br/>History?</b>"}

        REC1["<b>HIGH BARRIER</b><br/>INSTI + NRTI<br/>d ≈ 11.2"]
        REC2["<b>MODERATE</b><br/>INSTI + NNRTI<br/>d ≈ 10.5"]
        REC3["<b>AVOID</b><br/>NNRTI + PI alone<br/>d ≈ 8.9"]
    end

    Q1 --> Q2 --> Q3
    Q3 -->|"No resistance"| REC1
    Q3 -->|"Some history"| REC2
    Q3 -->|"Complex"| REC3

    style REC1 fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:3px
    style REC2 fill:#eab308,stroke:#ca8a04,color:#ffffff,stroke-width:2px
    style REC3 fill:#ef4444,stroke:#dc2626,color:#ffffff,stroke-width:2px
    style Q1 fill:#3b82f6,stroke:#1e40af,color:#ffffff
    style Q2 fill:#3b82f6,stroke:#1e40af,color:#ffffff
    style Q3 fill:#3b82f6,stroke:#1e40af,color:#ffffff
```

---

## Application 3: Combination Therapy Optimization

### Geometric Barrier Concept

```mermaid
flowchart TB
    subgraph BARRIER["<b>Total Escape Barrier</b>"]
        D1["<b>Drug 1 Escape d</b>"] --> TOTAL["<b>TOTAL BARRIER</b><br/>= d₁ + d₂ + d₃"]
        D2["<b>Drug 2 Escape d</b>"] --> TOTAL
        D3["<b>Drug 3 Escape d</b>"] --> TOTAL

        TOTAL --> HIGH["<b>HIGH = Durable</b><br/>d > 10"]
        TOTAL --> LOW["<b>LOW = Risky</b><br/>d < 9"]
    end

    style HIGH fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
    style LOW fill:#ef4444,stroke:#dc2626,color:#ffffff,stroke-width:2px
    style TOTAL fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
```

### Combination Rankings

| Combination             | Components      | Total Barrier | Recommendation |
| :---------------------- | :-------------- | :------------ | :------------- |
| **INSTI + NRTI + NRTI** | DTG + TAF + FTC | ~15.1         | OPTIMAL        |
| **INSTI + NRTI**        | DTG + TAF       | ~11.2         | Excellent      |
| **INSTI + NNRTI**       | DTG + EFV       | ~10.5         | Good           |
| NNRTI + NRTI            | EFV + TDF       | ~9.5          | Moderate       |
| NNRTI + PI              | EFV + ATV       | ~8.9          | Caution        |

---

## Application 4: Elite Controller Research

### Geometric Trap Identification

```mermaid
flowchart TB
    subgraph TRAP["<b>Identifying Geometric Traps</b>"]
        SCREEN["<b>Screen all<br/>HLA-epitope pairs</b>"]
        ENCODE["<b>Encode epitopes<br/>+ escape variants</b>"]
        CALC["<b>Calculate<br/>escape distances</b>"]
        FILTER["<b>Filter d > 6.0</b>"]
        TARGET["<b>Elite Controller<br/>Targets</b>"]
    end

    SCREEN --> ENCODE --> CALC --> FILTER --> TARGET

    style TARGET fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:3px
    style SCREEN fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style FILTER fill:#ef4444,stroke:#dc2626,color:#ffffff,stroke-width:2px
```

### Known High-Distance Epitopes

```mermaid
flowchart LR
    subgraph ELITE["<b>Elite Controller Epitopes (d > 6.0)</b>"]
        E1["<b>KK10 / B27</b><br/>d = 7.38"]
        E2["<b>FL8 / A24</b><br/>d = 7.37"]
        E3["<b>TW10 / B57</b><br/>d = 6.34"]
    end

    VACCINE["<b>CTL-Based<br/>Vaccine</b>"] --> ELITE

    style E1 fill:#ef4444,stroke:#dc2626,color:#ffffff,stroke-width:3px
    style E2 fill:#f97316,stroke:#ea580c,color:#ffffff,stroke-width:2px
    style E3 fill:#eab308,stroke:#ca8a04,color:#ffffff,stroke-width:2px
    style VACCINE fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
```

---

## Application 5: Glycan Editing Therapy (Novel)

### Concept

```mermaid
flowchart TB
    subgraph EDIT["<b>Glycan Editing Therapy</b>"]
        GAC["<b>Glycosidase-Antibody Conjugate</b>"]

        STEP1["<b>1. Antibody targets</b><br/>HIV Env on infected cell"]
        STEP2["<b>2. Glycosidase removes</b><br/>sentinel glycans"]
        STEP3["<b>3. Epitopes exposed</b><br/>to bnAbs"]
        STEP4["<b>4. bnAbs bind &</b><br/>clear infected cell"]
    end

    GAC --> STEP1 --> STEP2 --> STEP3 --> STEP4

    RESERVOIR["<b>Latent<br/>Reservoir</b>"] --> |"Targeted"| STEP1
    CURE["<b>Functional<br/>Cure?</b>"] --> STEP4

    style GAC fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:3px
    style CURE fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
    style RESERVOIR fill:#ef4444,stroke:#dc2626,color:#ffffff,stroke-width:2px
```

### Development Pathway

```mermaid
gantt
    title Glycan Editing Development
    dateFormat YYYY-MM
    section In Vitro
        Glycosidase selection       :done, 2025-01, 3M
        Conjugation chemistry       :active, 2025-04, 4M
        Cell-based assays           :2025-08, 4M
    section In Vivo
        Animal model design         :2026-01, 3M
        Efficacy testing            :2026-04, 6M
        Toxicology                  :2026-10, 6M
    section Clinical
        IND preparation             :2027-04, 6M
        Phase I trial               :2027-10, 12M
```

---

## Application 6: Universal Vaccine Targets

### Cross-Clade Sentinel Analysis

```mermaid
flowchart TB
    subgraph UNIVERSAL["<b>Universal Vaccine Target Discovery</b>"]
        CLADES["<b>Analyze all<br/>HIV-1 Clades</b>"]
        SENTINEL["<b>Run sentinel<br/>analysis per clade</b>"]
        INTERSECT["<b>Find intersection:<br/>Conserved sentinels</b>"]
        DESIGN["<b>Design universal<br/>immunogen</b>"]
    end

    CLADES --> SENTINEL --> INTERSECT --> DESIGN

    CLADE_A["Clade A"] --> CLADES
    CLADE_B["Clade B"] --> CLADES
    CLADE_C["Clade C"] --> CLADES
    CLADE_D["Clade D"] --> CLADES
    CRF["CRFs"] --> CLADES

    style DESIGN fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:3px
    style CLADES fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style INTERSECT fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:2px
```

---

## Application 7: Computational Platform

### API Concept

```mermaid
flowchart LR
    subgraph API["<b>HIV P-Adic API</b>"]
        ANALYZE["<b>analyze_mutation()</b>"]
        RANK["<b>rank_epitopes()</b>"]
        OPTIMIZE["<b>optimize_immunogen()</b>"]
        PREDICT["<b>predict_resistance()</b>"]
    end

    USER["<b>Researcher</b>"] --> API
    API --> RESULTS["<b>Results:</b><br/>Distances, Rankings,<br/>Designs"]

    style API fill:#3b82f6,stroke:#1e40af,color:#ffffff,stroke-width:2px
    style USER fill:#8b5cf6,stroke:#7c3aed,color:#ffffff,stroke-width:2px
    style RESULTS fill:#22c55e,stroke:#15803d,color:#ffffff,stroke-width:2px
```

### Example Usage

```python
from hiv_padic import HIVAnalyzer

# Initialize with encoder
analyzer = HIVAnalyzer(encoder="3adic_v5.11.3")

# Analyze a mutation
result = analyzer.analyze_mutation("RT", "M184V")
print(f"Escape distance: {result.distance}")  # 4.00

# Rank epitopes for a patient
epitopes = analyzer.rank_epitopes(
    patient_hla=["B*27:05", "A*02:01"]
)
# Returns sorted by escape barrier

# Optimize immunogen design
design = analyzer.optimize_immunogen(
    target_bnabs=["VRC01", "PGT121"],
    max_sites=3
)
# Returns: ["N58Q", "N103Q", "N204Q"]

# Predict resistance risk
risk = analyzer.predict_resistance(
    patient_sequence="...",
    regimen=["DTG", "TAF", "FTC"]
)
# Returns per-mutation probability
```

---

## Impact Summary

```mermaid
quadrantChart
    title Application Impact vs Timeline
    x-axis Near-Term --> Long-Term
    y-axis Low Impact --> High Impact
    quadrant-1 "High-Impact Long-Term"
    quadrant-2 "High-Impact Near-Term"
    quadrant-3 "Lower Priority"
    quadrant-4 "Moderate Priority"

    "Combo Optimization": [0.15, 0.55]
    "Resistance Prediction": [0.25, 0.60]
    "Vaccine Design": [0.55, 0.80]
    "Elite Research": [0.60, 0.70]
    "Glycan Editing": [0.80, 0.90]
    "Functional Cure": [0.95, 0.95]
```

---

## Priority Matrix

| Application               | Timeline  | Impact         | Resources | Priority |
| :------------------------ | :-------- | :------------- | :-------- | :------- |
| Combo Optimization        | Immediate | Medium         | Low       | **1**    |
| Resistance Prediction     | 6-12 mo   | Medium         | Medium    | **2**    |
| Vaccine Immunogens        | 1-2 yr    | High           | High      | **3**    |
| Elite Controller Research | 2-3 yr    | High           | Medium    | **4**    |
| Glycan Editing            | 3-5 yr    | Very High      | Very High | **5**    |
| Functional Cure           | 5+ yr     | Transformative | Very High | **6**    |

---

## Related Documents

- [Drug Resistance Profiles](./01_DRUG_RESISTANCE_PROFILES.md)
- [Elite Controllers](./02_ELITE_CONTROLLERS.md)
- [Sentinel Glycans](./03_SENTINEL_GLYCANS.md)
- [Validation Results](./05_VALIDATION_RESULTS.md)

---

**Navigation:** [← Sentinel Glycans](./03_SENTINEL_GLYCANS.md) | [Index](./README.md) | [Validation →](./05_VALIDATION_RESULTS.md)
